Genetic Analysis AS (XSAT:GEAN)
Sweden flag Sweden · Delayed Price · Currency is SEK · Price in NOK
0.8050
-0.0350 (-4.17%)
At close: Aug 15, 2025

Genetic Analysis AS Company Description

Genetic Analysis AS, a science-based diagnostic company, develops diagnostic solutions for human microbiome market in the United States, Europe, and internationally.

It offers GA-map, a platform for the analysis of the human gut microbiota; GA-map Dysbiosis Test that detects and characterizes dysbiosis; and GA-map Analyzer, a cloud-based software solution.

The company also provides GA-map Discovery, a tool to search biomarkers and validate research findings or transfer the findings to a ready-to-use routine testing platform; GA-map Sample Collection Kit used for collection, transport, and storage of fecal specimens for nucleic acid analyses; and GA-map Covid-19 Fecal Test, a non-invasive test with an easy-to-use home sampling procedure.

Further, it offers laboratory services; and bioinformatic analysis services. The company develops rapid microbiome-based PCR test.

Genetic Analysis AS was founded in 2008 and is headquartered in Oslo, Norway.

Genetic Analysis AS
CountryNorway
Founded2008
IndustryIn Vitro and In Vivo Diagnostic Substances
Employees16
CEORonny Hermansen

Contact Details

Address:
Ulvenveien 80B
Oslo, 0581
Norway
Phone47 48 32 16 10
Websitegenetic-analysis.com

Stock Details

Ticker SymbolGEAN
ExchangeSpotlight Stock Market
Fiscal YearJanuary - December
Reporting CurrencyNOK
SIC Code2835

Key Executives

NamePosition
Ronny HermansenChief Executive Officer
Lars TillerChief Operating Officer